DK1778193T3 - Farmaceutisk partikelsammensætning til udstrakt frigivelse omfattende venlafaxin - Google Patents

Farmaceutisk partikelsammensætning til udstrakt frigivelse omfattende venlafaxin

Info

Publication number
DK1778193T3
DK1778193T3 DK05768606T DK05768606T DK1778193T3 DK 1778193 T3 DK1778193 T3 DK 1778193T3 DK 05768606 T DK05768606 T DK 05768606T DK 05768606 T DK05768606 T DK 05768606T DK 1778193 T3 DK1778193 T3 DK 1778193T3
Authority
DK
Denmark
Prior art keywords
venlafaxine
release pharmaceutical
particle composition
pharmaceutical particle
extensive release
Prior art date
Application number
DK05768606T
Other languages
English (en)
Inventor
Robert Pisek
Silvo Zupancic
Zakelj Mojca Segula
Original Assignee
Krka Tovarna Zdravil D D Novo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil D D Novo filed Critical Krka Tovarna Zdravil D D Novo
Application granted granted Critical
Publication of DK1778193T3 publication Critical patent/DK1778193T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05768606T 2004-07-28 2005-07-27 Farmaceutisk partikelsammensætning til udstrakt frigivelse omfattende venlafaxin DK1778193T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004036641A DE102004036641A1 (de) 2004-07-28 2004-07-28 Verzögert freisetzende pharmazeutische Zusammensetzung, die Venlafaxin enthält
PCT/EP2005/008149 WO2006010605A2 (en) 2004-07-28 2005-07-27 Sustained release pharmaceutical particulate composition comprising venlafaxine

Publications (1)

Publication Number Publication Date
DK1778193T3 true DK1778193T3 (da) 2008-02-04

Family

ID=35106687

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05768606T DK1778193T3 (da) 2004-07-28 2005-07-27 Farmaceutisk partikelsammensætning til udstrakt frigivelse omfattende venlafaxin

Country Status (16)

Country Link
EP (1) EP1778193B1 (da)
AT (1) ATE381925T1 (da)
CY (1) CY1107187T1 (da)
DE (2) DE102004036641A1 (da)
DK (1) DK1778193T3 (da)
EA (1) EA009957B1 (da)
ES (1) ES2299061T3 (da)
HR (1) HRP20080007T3 (da)
NO (1) NO20071139L (da)
PL (1) PL1778193T3 (da)
PT (1) PT1778193E (da)
RS (1) RS50572B (da)
SI (1) SI1778193T1 (da)
UA (1) UA83437C2 (da)
WO (1) WO2006010605A2 (da)
ZA (1) ZA200701554B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722458B2 (en) * 2011-12-02 2020-07-28 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
EP1474123A1 (en) * 2002-01-03 2004-11-10 LEK Pharmaceuticals D.D. Controlled release pharmaceutical formulation containing venlafaxine
BR0312445A (pt) * 2002-06-07 2005-05-10 Ranbaxy Lab Ltd Sistemas multiunitários para disponibilização de fármaco de liberação modificada
WO2004047718A2 (en) * 2002-11-28 2004-06-10 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci

Also Published As

Publication number Publication date
ZA200701554B (en) 2008-05-28
NO20071139L (no) 2007-02-28
CY1107187T1 (el) 2012-10-24
ATE381925T1 (de) 2008-01-15
PT1778193E (pt) 2008-03-10
DE602005004033D1 (de) 2008-02-07
SI1778193T1 (sl) 2008-06-30
EA009957B1 (ru) 2008-04-28
UA83437C2 (uk) 2008-07-10
EP1778193B1 (en) 2007-12-26
DE602005004033T2 (de) 2009-01-02
EA200700159A1 (ru) 2007-06-29
EP1778193A2 (en) 2007-05-02
HRP20080007T3 (en) 2008-01-31
WO2006010605A2 (en) 2006-02-02
RS50572B (sr) 2010-05-07
DE102004036641A1 (de) 2006-03-23
PL1778193T3 (pl) 2008-05-30
WO2006010605A3 (en) 2006-09-21
ES2299061T3 (es) 2008-05-16

Similar Documents

Publication Publication Date Title
WO2008006715A3 (en) Improvements relating to pharmaceutical compositions
WO2009154777A3 (en) Process for preparing and drying solid rasagiline base
WO2005117843A3 (en) Sustained release preparations
WO2006089674A3 (en) Tablets with improved drug substance dispersibility
MY150087A (en) Composition and microsphere for controlled- release of exendin, and method of preparing the same
WO2008063910A3 (en) Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
JP2007302683A5 (da)
WO2006032026A3 (en) Long acting injectable crystal formulations of estradiol metabolites and methods of using same
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
WO2008091670A3 (en) Organic semiconductor materials and precursors thereof
JP2009515210A5 (da)
BRPI0506283A (pt) composição, método, e, artigo
JP2008521971A5 (da)
WO2009080628A3 (en) Kit comprising an alginate and a complexing agent in the form of a water-soluble salt
WO2010007312A3 (fr) Procede de fabrication de films directement en alveole
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
JP2009519849A5 (da)
NZ592882A (en) Mucoadhesive film comprising testosterone and cellulose derivatives
TW200621307A (en) Solid dispersion composition of pranlukast with improved bioavailibility and the method of preparing the solid dispersion
WO2008049633A3 (en) Spray-freeze-drying process for the preparation of pellets comprising percolation drying
WO2009033112A3 (en) Highly porous, large polymeric particles and methods of preparation and use
WO2010020799A3 (en) Compositions for the treatment of neoplastic diseases
DK1871180T3 (da) Fremgangsmåde til tørring af uronsyreoligosaccharider
EP2551266A8 (en) 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof
DK1778193T3 (da) Farmaceutisk partikelsammensætning til udstrakt frigivelse omfattende venlafaxin